Connect with us

Stock News

Ascendis Pharma’s stock surges after FDA approval for first and only treatment for rare disease

Published

on


The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

Continue Reading

Stock News

M&A should get a boost from Trump’s election — but most deals are doomed to fail

Published

on


CEOs face pressure to do ‘something big’ but more often do something wrong.

Continue Reading

Stock News

This Fed-based market signal is flashing a warning for the first time in over a decade. Here’s why it matters.

Published

on


Bears are hoping this earnings-based stock-market predictor will be right — for once.

Continue Reading

Stock News

Super Micro has a plan for its delayed reports, names new auditor; stock jumps

Published

on


Super Micro’s stock rallies after news that staves off delisting — at least for now.

Continue Reading

Trending